Femme et Homme
- | Pays :
- South Africa
- United States
- Switzerland
- Les 5 autres...
- | Organes : -
- | Spécialités : -
Extrait
This open-label extension study will allow subjects who have completed either the 3242K1-2000-WW or 3242K1-2001-JA study to receive up to an additional 48 weeks of ATN-103 treatment and will provide data on the long-term safety and tolerability of ATN-103 in subjects with rheumatoid arthritis.
Critère d'inclusion
- Rheumatoid Arthritis